Hainan Poly Pharm Co, Ltd

The company was founded in 1992 and is a high-tech enterprise specializing in R&D, production and sales of generic pharmaceuticals and innovative drugs. It is one of the few leading international pharmaceutical companies in China. It is a group company specializing in R&D, production and sales of chemical raw materials and pharmaceutical preparations for the world. The company is a high-tech enterprise specializing in drug research and development, registration, production and sales. The products sold by the company are mainly prescription drugs, covering fields such as anti-allergic drugs, non-steroidal analgesic and anti-inflammatory drugs, antibiotics, digestive drugs, etc., cardiovascular, contrast agents, and first aid drugs. Corporate honors: “Development, production and transformation of diclofenac sodium enteric sustained-release capsules” project won the second prize in Hainan Science and Technology, the “Development and Industrialization of Desloratadine Dry Suspension” project won the third prize of Hainan Science and Technology, and “Fubiding (desloratadine dry suspension)” was rated as an excellent product in the pharmaceutical industry in Hainan Province by the Hainan Pharmaceutical Industry Association. Desloratadine dispersible tablets and desloratadine dry suspension won the “28th National Pharmaceutical Economic Information Conference” China Pharmaceutical Brand List 2016 List of 2 brands for hospital terminals and primary terminals (in the category of antiallergic drugs), pharmaceutical industry The 13th Five-Year “Enterprise Management Award” won the honors of “2024 China's Top 100 Comprehensive Drug Research and Development Capabilities” and “2024 China's Top 50 Chemical Pharmaceutical Research and Development Capabilities”.